🌼 Allergic Conjunctivitis Co-Occurrence Simulator

Ocular Mast Cell Activation

Pollen allergens cross-link IgE on conjunctival mast cells.

• ~50: Mast cells / mm² (Conjunctival density)
• <1 s: IgE cross-link time (Triggers degranulation)
• Immediate: Histamine release (Vasoactive amine burst)
• Seconds: Reaction onset (Early-phase response)

IgE-mediated trigger

Pollen binds surface IgE, cross-linking mast cell receptors.

Degranulation cascade

Granules release histamine, tryptase, and prostaglandins quickly.

More pollen exposure means faster, stronger degranulation onset.

Itching and Redness Onset

Histamine dilates conjunctival vessels, producing itch and redness.

• Rapid: Vessel dilation (Histamine-driven)
• H1 receptor: Itch mediator (Sensory nerve activation)
• ~15 min: Redness peak (Post-exposure)
• Itch+Red: Symptom pair (Hallmark combo)

Vascular response

Dilated capillaries give the conjunctiva a visible pink-red hue.

Sensory itch signal

H1 receptors on nerve endings fire, producing itch sensation.

Itch severity scales directly with local histamine concentration.

Tearing / Watery Discharge Response

Reflex lacrimation floods the eye to dilute allergens.

• Up to 5x: Tear flow increase (Above baseline)
• Watery, clear: Discharge type (Non-purulent)
• Trigeminal reflex: Trigger (Sensory nerve arc)
• Minutes-hours: Duration (While exposed)

Reflex arc

Irritation signals travel via trigeminal nerve to lacrimal glands.

Dilution function

Excess tears help wash allergen particles from the ocular surface.

Heavier pollen exposure drives proportionally heavier tearing.

Parallel Nasal Symptom Occurrence

The same pollen exposure triggers nasal mucosa in parallel.

• ~70-80%: Co-occurrence rate (Rhinitis + conjunctivitis)
• Congestion, sneeze: Nasal symptoms (Shared trigger)
• Simultaneous: Timing (Same allergen exposure)
• Rhinoconjunctivitis: Condition name (Combined diagnosis)

Shared mucosal trigger

Nasal and conjunctival mucosa share mast cell allergic pathways.

Correlated severity

Nasal congestion severity tracks closely with ocular symptom intensity.

High nasal-ocular correlation supports combined treatment strategies.

Combined Antihistamine / Eye Drop Management

Oral antihistamines and topical eye drops reduce both symptom sets.

• Minutes: Topical drop onset (Fast relief)
• Systemic: Oral antihistamine (Covers nasal+ocular)
• Up to 60%: Symptom reduction (Combined therapy)
• Dual therapy: Recommended approach (Drops + oral agent)

Topical antihistamine drops

Drops block ocular H1 receptors, easing itch and redness fast.

Systemic coverage

Oral antihistamines address nasal symptoms occurring in parallel.

Combined therapy outperforms single-site treatment for rhinoconjunctivitis.